Xiaoyan Chen
0000-0002-6559-8627
Publication & Citation Trends
Publications
0 total
Tertiary lymphoid structures in breast ductal carcinoma in situ correlate with adverse pathological parameters
Cited by 9
Semantic Scholar
More microinvasive foci in larger tumours of breast ductal carcinoma in situ OA
Cited by 1
Semantic Scholar
Harnessing the Immunogenic Potential of Gold Nanoparticle-Based Platforms as a Therapeutic Strategy in Breast Cancer Immunotherapy: A Mini Review OA
Cited by 16
Semantic Scholar
Delineating the breast cancer immune microenvironment in the era of multiplex immunohistochemistry/immunofluorescence
Cited by 12
Semantic Scholar
Identifying a new therapeutic target for bone metastasis of breast cancer OA
Cited by 0
Semantic Scholar
Higher density of stromal M2 macrophages in breast ductal carcinoma in situ predicts recurrence
Cited by 20
Semantic Scholar
Breast ductal Carcinoma in situ associated with microinvasion induces immunological response and predicts ipsilateral invasive recurrence
Cited by 10
Semantic Scholar
Research Topics
Pharmacogenetics and Drug Metabolism
(35)
Analytical Methods in Pharmaceuticals
(25)
Antibiotics Pharmacokinetics and Efficacy
(24)
Drug Transport and Resistance Mechanisms
(23)
Analytical Chemistry and Chromatography
(16)
Affiliations
Shenyang Pharmaceutical University
Shanghai University
Nanjing University of Chinese Medicine
IBM (United States)
Guiyang Medical University